Astrion Co. specializes in the development of innovative new drugs for incurable brain diseases, aiming to enhance the quality of life for patients.

Vision and Mission: Committed to pioneering advancements in neuropharmacology, Astrion Co. envisions a world where brain diseases are no longer life sentences.

Noteworthy Points:

• Founded in 2021, Astrion Co. is a beacon of hope in drug discovery.
• Backed by Korea University Holdings and Tech Incubator Program for Startups.
• Led by CEOs Jaeyong Park and Indeok Jeong, experts in neuropharmacology.